Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
At the completion of this activity, the participant will be able to:
Describe the role of anticoagulation in the management of atrial fibrillation
Discuss the indications and optimal antithrombotic management of patients undergoing percutaneous coronary intervention
Recall literature assessing the efficacy and safety of various antithrombotic therapy strategies in patients with atrial fibrillation who are undergoing percutaneous coronary intervention
State strategies to mitigate bleeding risk when designing antithrombotic therapy regimens for a patient case
A Zoom Link will be emailed to you the day before the event.
Dr. Susan Mirzakandov, PharmD, PGY2 Ambulatory Care Resident
Dr. Susan Mirzakandov is a PGY-2 Ambulatory Care Pharmacy Resident at The Brooklyn Hospital Center in Brooklyn, NY. She graduated from Arnold and Marie Shwartz College of Pharmacy at Long Island University in 2022 and proceeded to complete a PGY-1 residency at Lenox Hill Hospital in New York, NY. She currently has interests in HIV and Cardiology and plans to become a board-certified ambulatory care pharmacist upon completion of her PGY-2 residency.
ACPE UAN# 0042-0000-23-095-L01-P
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.